1-8 of 8
Paolo Rossetti
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Metabolism of Insulin Glargine After Repeated Daily Subcutaneous Injections in Subjects With Type 2 Diabetes

Paola Lucidi, MD, Francesca Porcellati, MD, Paolo Rossetti, MD, Paola Candeloro, PHD, Anna Marinelli Andreoli, MD, Patrizia Cioli, RD, Annke Hahn, PHD, Ronald Schmidt, PHD, Geremia B. Bolli, MD, Carmine G. Fanelli, MD
Journal: Diabetes Care
Diabetes Care 2012;35(12):2647–2649
https://doi.org/10.2337/dc12-0271
Published: 14 November 2012
View article titled, Metabolism of Insulin Glargine After Repeated Daily Subcutaneous Injections in Subjects With Type 2 Diabetes
Open the PDF for Metabolism of Insulin Glargine After Repeated Daily Subcutaneous Injections in Subjects With Type 2 Diabetes in another window
Includes: Supplementary data
Journal Articles

Differential Effects of Adiposity on Pharmacodynamics of Basal Insulins NPH, Glargine, and Detemir in Type 2 Diabetes Mellitus

Francesca Porcellati, MD, Paola Lucidi, MD, Paolo Rossetti, MD, Paola Candeloro, PHD, Anna Marinelli Andreoli, MD, Stefania Marzotti, MD, Patrizia Cioli, RD, Geremia B. Bolli, MD, Carmine G. Fanelli, MD
Journal: Diabetes Care
Diabetes Care 2011;34(12):2521–2523
https://doi.org/10.2337/dc11-1064
Published: 14 November 2011
View article titled, Differential Effects of Adiposity on Pharmacodynamics of Basal Insulins NPH, Glargine, and Detemir in Type 2 Diabetes Mellitus
Open the PDF for Differential Effects of Adiposity on Pharmacodynamics of Basal Insulins NPH, Glargine, and Detemir in Type 2 Diabetes Mellitus in another window
Includes: Supplementary data
Journal Articles

Pharmacokinetics and Pharmacodynamics of Therapeutic Doses of Basal Insulins NPH, Glargine, and Detemir After 1 Week of Daily Administration at Bedtime in Type 2 Diabetic Subjects: A randomized cross-over study

Paola Lucidi, MD, Francesca Porcellati, MD, Paolo Rossetti, MD, Paola Candeloro, PHD, Patrizia Cioli, RD, Stefania Marzotti, MD, Anna Marinelli Andreoli, MD, Raffaela Fede, MD, Geremia B. Bolli, MD, Carmine G. Fanelli, MD
Journal: Diabetes Care
Diabetes Care 2011;34(6):1312–1314
https://doi.org/10.2337/dc10-1911
Published: 20 May 2011
View article titled, Pharmacokinetics and Pharmacodynamics of Therapeutic Doses of Basal Insulins NPH, Glargine, and Detemir After 1 Week of Daily Administration at Bedtime in Type 2 Diabetic Subjects: <subtitle>A randomized cross-over study</subtitle>
Open the PDF for Pharmacokinetics and Pharmacodynamics of Therapeutic Doses of Basal Insulins NPH, Glargine, and Detemir After 1 Week of Daily Administration at Bedtime in Type 2 Diabetic Subjects: <subtitle>A randomized cross-over study</subtitle> in another window
Includes: Supplementary data
Journal Articles

Comparison of Pharmacokinetics and Dynamics of the Long-Acting Insulin Analogs Glargine and Detemir at Steady State in Type 1 Diabetes: a Double-Blind, Randomized, Crossover Study: Response to Banarer

Francesca Porcellati, MD, Paolo Rossetti, MD, Geremia B. Bolli, MD, Carmine G. Fanelli, MD
Journal: Diabetes Care
Diabetes Care 2008;31(3):e17
https://doi.org/10.2337/dc07-2234
Published: 01 March 2008
View article titled, Comparison of Pharmacokinetics and Dynamics of the Long-Acting Insulin Analogs Glargine and Detemir at Steady State in Type 1 Diabetes: a Double-Blind, Randomized, Crossover Study: <subtitle>Response to Banarer</subtitle>
Open the PDF for Comparison of Pharmacokinetics and Dynamics of the Long-Acting Insulin Analogs Glargine and Detemir at Steady State in Type 1 Diabetes: a Double-Blind, Randomized, Crossover Study: <subtitle>Response to Banarer</subtitle> in another window
Journal Articles

Prevention of Hypoglycemia While Achieving Good Glycemic Control in Type 1 Diabetes : The role of insulin analogs

Paolo Rossetti, MD, Francesca Porcellati, MD, PHD, Geremia B. Bolli, MD, Carmine G. Fanelli, MD, PHD
Journal: Diabetes Care
Diabetes Care 2008;31(Supplement_2):S113–S120
https://doi.org/10.2337/dc08-s227
Published: 01 February 2008
View article titled, Prevention of Hypoglycemia While Achieving Good Glycemic Control in Type 1 Diabetes : <subtitle>The role of insulin analogs</subtitle>
Open the PDF for Prevention of Hypoglycemia While Achieving Good Glycemic Control in Type 1 Diabetes : <subtitle>The role of insulin analogs</subtitle> in another window
Journal Articles

Comparison of Pharmacokinetics and Dynamics of the Long-Acting Insulin Analogs Glargine and Detemir at Steady State in Type 1 Diabetes: A double-blind, randomized, crossover study

Francesca Porcellati, MD, Paolo Rossetti, MD, Natalia Ricci Busciantella, MD, Stefania Marzotti, MD, Paola Lucidi, MD, Steven Luzio, MD, David R. Owens, MD, Geremia B. Bolli, MD, Carmine G. Fanelli, MD
Journal: Diabetes Care
Diabetes Care 2007;30(10):2447–2452
https://doi.org/10.2337/dc07-0002
Published: 01 October 2007
View article titled, Comparison of Pharmacokinetics and Dynamics of the Long-Acting Insulin Analogs Glargine and Detemir at Steady State in Type 1 Diabetes: <subtitle>A double-blind, randomized, crossover study</subtitle>
Open the PDF for Comparison of Pharmacokinetics and Dynamics of the Long-Acting Insulin Analogs Glargine and Detemir at Steady State in Type 1 Diabetes: <subtitle>A double-blind, randomized, crossover study</subtitle> in another window
Includes: Supplementary data
Journal Articles

Pharmacokinetics and Pharmacodynamics of the Long-Acting Insulin Analog Glargine After 1 Week of Use Compared With Its First Administration in Subjects With Type 1 Diabetes

Francesca Porcellati, MD, Paolo Rossetti, MD, Natalia Busciantella Ricci, MD, Simone Pampanelli, MD, Elisabetta Torlone, MD, Susana Hernandez Campos, MD, Anna Marinelli Andreoli, MD, Geremia B. Bolli, MD, Carmine G. Fanelli, MD
Journal: Diabetes Care
Diabetes Care 2007;30(5):1261–1263
https://doi.org/10.2337/dc06-2208
Published: 01 May 2007
View article titled, Pharmacokinetics and Pharmacodynamics of the Long-Acting Insulin Analog Glargine After 1 Week of Use Compared With Its First Administration in Subjects With Type 1 Diabetes
Open the PDF for Pharmacokinetics and Pharmacodynamics of the Long-Acting Insulin Analog Glargine After 1 Week of Use Compared With Its First Administration in Subjects With Type 1 Diabetes in another window
Journal Articles

Intensive Replacement of Basal Insulin in Patients With Type 1 Diabetes Given Rapid-Acting Insulin Analog at Mealtime: A 3-month comparison between administration of NPH insulin four times daily and glargine insulin at dinner or bedtime

Paolo Rossetti, MD, Simone Pampanelli, MD, Carmine Fanelli, MD, Francesca Porcellati, MD, Emanuela Costa, MD, Elisabetta Torlone, MD, Luciano Scionti, MD, Geremia B. Bolli, MD
Journal: Diabetes Care
Diabetes Care 2003;26(5):1490–1496
https://doi.org/10.2337/diacare.26.5.1490
Published: 01 May 2003
View article titled, Intensive Replacement of Basal Insulin in Patients With Type 1 Diabetes Given Rapid-Acting Insulin Analog at Mealtime: <subtitle>A 3-month comparison between administration of NPH insulin four times daily and glargine insulin at dinner or bedtime </subtitle>
Open the PDF for Intensive Replacement of Basal Insulin in Patients With Type 1 Diabetes Given Rapid-Acting Insulin Analog at Mealtime: <subtitle>A 3-month comparison between administration of NPH insulin four times daily and glargine insulin at dinner or bedtime </subtitle> in another window